Regulatory T-cell deficiency and autoimmune skin disease: Beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked.

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
“Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events  Keiichi Yamanaka, MD, PhD, Hitoshi.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Clarification concerning amoxicillin skin testing
CD39: A new surface marker of mouse regulatory γδ T cells
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D
Atopic dermatitis: Age and race do matter!
The Editors' Choice Journal of Allergy and Clinical Immunology
Biologics in patients with skin diseases
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Thomas F. Tedder, PhD, Takashi Matsushita, MD, PhD 
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling  David Bending, PhD,
A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180  Manabu Osawa, MD, Ikuko Ueda-Hayakawa, MD, PhD, Taiki.
Refractory oral ulcers with multiple immunoglobulin G/immunoglobulin A autoantibodies without skin lesions  Teruki Dainichi, MD, Bungo Ohyama, MD, Norito.
David J. Cousins, PhD, Joanne McDonald, BSc, Tak H. Lee, MD, ScD 
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Takashi Hashimoto, Norito Ishii, Daisuke Tsuruta 
The National Biome Initiative: An allergy perspective
Clinical characteristics and genotype-phenotype correlations in C3 deficiency  Yuka Okura, MD, PhD, Ichiro Kobayashi, MD, PhD, Masafumi Yamada, MD, PhD,
Peter M. Wolfgram, MD, David B. Allen, MD 
Jonathan H. Esensten, MD, PhD, Yannick D. Muller, MD, PhD, Jeffrey A
John J. Zone, C. Anthony Egan, Ted B. Taylor 
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Ricardo U. Sorensen, MD, Luke A. Wall, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
What are the best outcome measurements for atopic eczema
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Christian Hennig, MD, Christine Happle, MD, Gesine Hansen, MD 
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
What is an “eosinophilic phenotype” of asthma?
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Cephalosporin Side Chain Cross-reactivity
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Role of regulatory T cells and FOXP3 in human diseases
Autophagy: Nobel Prize 2016 and allergy and asthma research
Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy.
Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies  Phillip Lieberman, MD, Rima Rachid, MD 
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
New pathways for itching in patients with atopic dermatitis?
News Beyond Our Pages Journal of Allergy and Clinical Immunology
One step forward, 2 steps back: The enigma of preschool wheeze
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells  Troy R. Torgerson, MD,
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Thymic output markers indicate immune dysfunction in DiGeorge syndrome
Innate immune responses to infection
Advances in basic and clinical immunology in 2013
Measles and immunomodulation
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X- linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes 
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Asthma: The past, future, environment, and costs
Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy– treated mother  Sabine Flicker, PhD, Katharina Marth, MD, Heinz.
Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria  Sridharan Soundararajan, PhD, Yoko Kikuchi, DVM, Kusumam Joseph, PhD,
Environmental factors and eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Regulatory T-cell deficiency and autoimmune skin disease: Beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome  Takashi Hashimoto, MD, Hayato Takahashi, MD, PhD, Shimon Sakaguchi, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 142, Issue 6, Pages 1754-1756 (December 2018) DOI: 10.1016/j.jaci.2018.08.028 Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Illustrations for cellular and humoral immunity-related findings in the study by Muramatsu et al.8 A, Schematic presentations of how Treg cell dysfunction leads to abnormal skin conditions in scurfy mice or patients with IPEX syndrome, as well as a possible disease process in the development of blister formation in patients with BP. ?, Issues that should be confirmed in future studies. B, Schematic presentations of protein structures of human BP180 and BP230 and differences in immune reactivity. Beneath the schematic structures of both BP180 and BP230, positive domains are shown for (1) pathogenicity in passive transfer mouse disease models, (2) autoantibodies in patients with BP, (3) autoantibodies in scurfy mouse sera, and (4) autoantibodies in sera from patients with IPEX syndrome. Shaded rectangles indicate positive domains. Positive rates for both scurfy mice and patients with IPEX syndrome in this study are shown within rectangles. Abs, Antibodies; C15 domain, 15th collagenous domain of BP180; DPP4, dipeptidyl peptidase 4; LABD, linear IgA bullous dermatosis; MMP, mucous membrane pemphigoid; NC16A domain, noncollagenous 16A domain of BP180 (corresponding to NC14A domain in murine BP180; Tfh, follicular helper T. Journal of Allergy and Clinical Immunology 2018 142, 1754-1756DOI: (10.1016/j.jaci.2018.08.028) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions